NCT06934083 Lifestyle Medicine Health Education and Intervention Program "Family Central E-Health" Status COMPLETED Phase NA
NCT06931028 A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2 Status RECRUITING Phase PHASE3
NCT06928571 Using Online Tools to Increase Weight Loss in Primary Care Status ENROLLING_BY_INVITATION Phase NA
NCT06926842 Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06922630 WIN: a Feasibility Study of a Weight-Neutral Health Intervention Status ACTIVE_NOT_RECRUITING Phase NA
NCT06916091 A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Overweight Status COMPLETED Phase PHASE1
NCT06916065 A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity Status COMPLETED Phase PHASE1
NCT06914895 A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06913231 Impact of Whole-Body Vibration on Anthropometric Measurement and Body Composition in Overweight and Obese University Students Status COMPLETED Phase NA
NCT06911879 The Effect of Ketogenic-caloric Restricted Diet on Metabolic Endotoxemia in Prediabetic Obese Adults Status COMPLETED Phase NA
NCT06910839 Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity Status TERMINATED Phase PHASE1
NCT06910735 Financial Incentives and Weight Loss in Failed Bariatric Surgery Status NOT_YET_RECRUITING Phase NA
NCT06904105 A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06903923 Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy Status RECRUITING Phase PHASE2
NCT06901349 A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes Status WITHDRAWN Phase PHASE2
NCT06896981 Semaglutide in Women With Polycystic Ovary Syndrome and Obesity Status RECRUITING Phase PHASE2/PHASE3